Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 11, 2011, Pages 811-818

  Abdallah, Dalaal M ^a   Ismael, Naglaa R ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Fayoum University   (Egypt)

Author keywords

Colitis; Myeloperoxidase; Oxidative stress; Resveratrol; Sulphasalazine

Indexed keywords

CELL ADHESION MOLECULE; FREE RADICAL; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; NITRIC OXIDE; RESVERATROL; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SERUM; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY WEIGHT; CELL ADHESION MOLECULES; COLITIS, ULCERATIVE; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GLUTATHIONE; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIPID PEROXIDATION; MALE; PEROXIDASE; RATS; RATS, WISTAR; STILBENES; SULFASALAZINE; TRINITROBENZENESULFONIC ACID; VASCULAR CELL ADHESION MOLECULE-1;

EID: 80055086477     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-080     Document Type: Article

References (48)

1. Ademoglu, E., Erbil, Y., Tam, B., Barbaros, U., Ilhan, E., Olgac, V., and Mutlu-Turkoglu, U. 2004. Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig. Dis. Sci. 49(1): 102-108. doi:10.1023/B: DDAS.0000011610.47179.0b.
2. Aihara, H., and Hiwatashi, N. 1999. Salazosulfapyridine and 5- aminosalicylic acid agents for the treatment of ulcerative colitis. [In Japanese]. Nippon Rinsho, 57(11): 2476-2480.
3. Arribas, B., Suárez-Pereira, E., Ortiz Mellet, C., García Fernández, J. M., Buttersack, C., Rodríguez-Cabezas, M.E., et al. 2010. Di-Dfructose dianhydride-enriched caramels: effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic rats. J. Agric. Food Chem. 58(10): 6476-6484. doi:10.1021/jf100513j.
4. Beutler, E., Duron, O., and Kelly, B.M. 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61: 882-888.
5. Colón, A.L., Madrigal, J.L., Menchén, L.A., Moro, M.A., Lizasoain, I., Lorenzo, P., and Leza, J.C. 2004. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig. Dis. Sci. 49(10): 1713-1721. doi:10.1023/B: DDAS.0000043391.64073.e4.
6. Cui, X., Jin, Y., Hofseth, A.B., Pena, E., Habiger, J., Chumanevich, A., et al. 2010. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev. Res. (Phila.), 3(4): 549-559. doi:10.1158/1940-6207.CAPR-09-0117.
7. De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, M.A., Jr, et al. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96(1): 60-68. doi:10.1172/JCI118074.
8. Deng, Y.H., Alex, D., Huang, H.Q., Wang, N., Yu, N., Wang, Y.T., et al. 2010. Inhibition of TNF-alpha-mediated endothelial cellmonocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4'-trimethoxystilbene. Phytother. Res. 25(3): 451-457.
9. Dey, A., Guha, P., Chattopadhyay, S., and Bandyopadhyay, S.K. 2009. Biphasic activity of resveratrol on indomethacin-induced gastric ulcers. Biochem. Biophys. Res. Commun. 381(1): 90-95. doi:10.1016/j.bbrc.2009.02.027.
10. Domènech, E. 2006. Inflammatory bowel disease: current therapeutic options. Digestion, 73(1 Suppl 1): 67-76. doi:10.1159/000089781.
11. Fan, H., Chen, R., Shen, L., Lv, J., Xiong, P., Shou, Z., and Zhuang, X. 2008. Oxymatrine improves TNBS-induced colitis in rats by inhibiting the expression of NF-κB p65. J. Huazhong Univ. Sci. Technolog. Med. Sci. 28(4): 415-420. doi:10.1007/s11596-008- 0409-x.
12. Ferrero, M.E., Bertelli, A.A.E., Fulgenzi, A., Pellegatta, F., Corsi, M. M., Bonfrate, M., et al. 1998. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am. J. Clin. Nutr. 68(6): 1208-1214.
13. Grisham, M.B., Volkmer, C., Tso, P., and Yamada, T. 1991. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology, 101(2): 540-547.
14. Hilsden, R.J., Meddings, J.B., and Verhoef, M.J. 1999. Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey. Can. J. Gastroenterol. 13(4): 327-332.
15. Hofseth, L.J., Singh, U.P., Singh, N.P., Nagarkatti, M., and Nagarkatti, P.S. 2010. Taming the beast within: resveratrol suppresses colitis and prevents colon cancer. Aging (Albany NY), 2(4): 183-184.
16. ILAR (Institute for Laboratory Animal Research). 1996. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 1996). National Academy Press, Washington, D.C. Available from www.nap.edu/openbook.php?record_id=5140.
17. Jung, M., Triebel, S., Anke, T., Richling, E., and Erkel, G. 2009. Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 53(10): 1263-1280. doi:10.1002/mnfr. 200800575.
18. Krawisz, J.E., Sharon, P., and Stenson, W.F. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology, 87(6): 1344-1350.
19. Kruidenier, L., Kuiper, I., Lamers, C.B., and Verspaget, H.W. 2003. Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants. J. Pathol. 201(1): 28-36. doi:10.1002/path.1409.
20. Kurtovic, J., and Segal, I. 2004. Recent advances in biological therapy for inflammatory bowel disease. Trop. Gastroenterol. 25 (1): 9-14.
21. Larrosa, M., Yañéz-Gascón, M.J., Selma, M.V., González-Sarrías, A., Toti, S., Cerón, J.J., et al. 2009. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J. Agric. Food Chem. 57(6): 2211-2220. doi:10.1021/jf803638d.
22. León, A.J., Gómez, E., Garrote, J.A., Bernardo, D., Barrera, A., Marcos, J.L., et al. 2009. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm. 2009: 1-10. doi:10.1155/2009/580450.
23. Li, J.H., Yu, J.P., Yu, H.G., Xu, X.M., Yu, L.L., Liu, J., and Luo, H.- S. 2005. Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators Inflamm. 2005(4): 185-193. doi:10.1155/MI.2005.185.
24. Martín, A.R., Villegas, I., La Casa, C., and de la Lastra, C.A. 2004. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem. Pharmacol. 67(7): 1399-1410. doi:10.1016/ j.bcp.2003.12.024.
25. Martín, A.R., Villegas, I., Sánchez-Hidalgo, M., and de la Lastra, C. A. 2006. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br. J. Pharmacol. 147(8): 873-885. doi:10. 1038/sj.bjp.0706469.
26. Mei, Q., Xu, J.M., Xiang, L., Hu, Y.M., Hu, X.P., and Xu, Z.W. 2005. Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad. Med. J. 81(960): 667-672. doi:10.1136/pgmj.2004.030817.
27. Mihara, M., and Uchiyama, M. 1978. Determination of malondialdhyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86(1): 271-278. doi:10.1016/0003-2697(78)90342-1.
28. Miranda, K.M., Espey, M.G., and Wink, D.A. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide, 5(1): 62-71. doi:10.1006/niox.2000. 0319.
29. Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M. R., and Wallace, J.L. 1989. Hapten-induced model of chronic inflammation and ulceration in rat colon. Gastroenterology, 96(3): 795-803.
30. Mudter, J., Weigmann, B., Bartsch, B., Kiesslich, R., Strand, D., Galle, P.R., et al. 2005. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100(1): 64-72. doi:10.1111/ j.1572-0241.2005.40615.x.
31. Neurath, M.F., Fuss, I., Kelsall, B.L., Stüber, E., and Strober, W. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182(5): 1281-1290. doi:10. 1084/jem.182.5.1281.
32. Panés, J., and Granger, D.N. 1998. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology, 114(5): 1066-1090. doi:10. 1016/S0016-5085(98)70328-2.
33. Park, H.J., Jeong, S.K., Kim, S.R., Bae, S.K., Kim, W.S., Jin, S.D., et al. 2009. Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide- induced endothelial adhesion molecule expression by suppressing NF-kappaB activation. Arch. Pharm. Res. 32(4): 583-591. doi:10.1007/s12272-009-1415-7.
34. Pfeiffer, C.J., and Qiu, B.S. 1995. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J. Pharm. Pharmacol. 47(10): 827-832. doi:10.1111/j.2042-7158.1995. tb05749.x.
35. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347(6): 417-429. doi:10.1056/NEJMra020831.
36. Salim, S.Y., and Söderholm, J.D. 2011. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm. Bowel Dis. 17(1): 362-381. doi:10.1002/ibd.21403.
37. Sánchez-Fidalgo, S., Cárdeno, A., Villegas, I., Talero, E., and de la Lastra, C.A. 2010. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol. 633(1-3): 78-84. doi:10.1016/j.ejphar.2010.01.025.
38. Sans, M., Panés, J., Ardite, E., Elizalde, J.I., Arce, Y., Elena, M., et al. 1999. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology, 116(4):874-883. doi:10.1016/S0016-5085(99)70070-3.
39. Seguí, J., Gironella, M., Sans, M., Granell, S., Gil, F., Gimeno, M., et al. 2004. Superoxide dismutase ameliorates TNBS- induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J. Leukoc. Biol. 76(3): 537-544. doi:10.1189/jlb.0304196.
40. Singh, K., Jaggi, A.S., and Singh, N. 2009. Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice. Phytother. Res. 23(11): 1565-1574. doi:10.1002/ptr.2822.
41. Singh, U.P., Singh, N.P., Singh, B., Hofseth, L.J., Price, R.L., Nagarkatti, M., and Nagarkatti, P.S. 2010. Resveratrol (trans- 3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-κB activation to abrogate dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 332(3): 829-839. doi:10.1124/jpet.109. 160838.
42. Wang, W.P., Guo, X., Koo, M.W., Wong, B.C., Lam, S.K., Ye, Y.N., and Cho, C.H. 2001. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 281(2): G586-G594.
43. Wung, B.S., Hsu, M.C., Wu, C.C., and Hsieh, C.W. 2005. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci. 78(4): 389-397. doi:10.1016/j.lfs.2005.04.052.
44. Yao, J., Wang, J.Y., Liu, L., Li, Y.X., Xun, A.Y., Zeng, W.S., et al. 2010. Anti-oxidant effects of resveratrol on mice with DSSinduced ulcerative colitis. Arch. Med. Res. 41(4): 288-294. doi:10.1016/j.arcmed.2010.05.002.
45. Yoshikawa, T., Yamaguchi, T., Yoshida, N., Yamamoto, H., Kitazumi, S., Takahashi, S., et al. 1997. Effect of Z-103 on TNB-induced colitis in rats. Digestion, 58(5): 464-468. doi:10. 1159/000201484.
46. Youn, J., Lee, J.S., Na, H.K., Kundu, J.K., and Surh, Y.J. 2009. Resveratrol and piceatannol inhibit iNOS expression and NF-kB activation in dextran sulfate sodium-induced mouse colitis. Nutr. Cancer, 61(6): 847-854. doi:10.1080/01635580903285072.
47. Yu, H.P., Hwang, T.L., Hwang, T.L., Yen, C.H., and Lau, Y.T. 2010. Resveratrol prevents endothelial dysfunction and aortic superoxide production after trauma hemorrhage through estrogen receptordependent hemeoxygenase-1 pathway. Crit. CareMed. 38(4): 1147-1154. doi:10.1097/CCM.0b013e3181cd124e.
48. Öhman, L., and Simrén, M. 2010. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat. Rev. Gastroenterol. Hepatol. 7(3): 163-173. doi:10.1038/nrgastro.2010. 4.